Olof Danielsson

Also affiliated with Linköping University Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “316P Differential long-term benefit of 2-year adjuvant tamoxifen therapy for luminal-type breast cancer: Insights from a 20-year follow-up analysis of the STO trials”.

316P Differential long-term benefit of 2-year adjuvant tamoxifen therapy for luminal-type breast cancer: Insights from a 20-year follow-up analysis of the STO trials

Annals of Oncology(2024)10.1016/j.annonc.2024.08.257

N/A

0DataRank · unranked

0 citations

Olof Danielsson, T. Fornander, Agneta Nordenskjöld, G. Pérez Tenorio, N.P. Tobin +6 more

315P Long-term tamoxifen benefit in pre- and postmenopausal patients of high and low risk with luminal A and B breast cancer

Annals of Oncology(2024)10.1016/j.annonc.2024.08.256

N/A

0DataRank · unranked

0 citations

Huma Dar, Agneta Nordenskjöld, G. Pérez Tenorio, CC Yau, CC Benz +9 more